Depending on VTE history, presence of thrombophilia, and use of a mechanical valve, the enoxaparin dose could be 40 mg SC once daily, 40 mg SC every 12 hours, 75% of treatment dose, or treatment ...

ISTH 2009The low–molecular-weight heparin enoxaparin is a safe and effective therapy to prevent symptomatic venous thromboembolism in patients undergoing chemotherapy for advanced pancreatic ...

Higher Risk of VTE in CKD Surgical Patients on Enoxaparin For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is ...

The researchers found that, compared with those receiving enoxaparin twice daily, once-daily enoxaparin correlated with a trend toward more VTE recurrences (odds ratio [OR], 1.79; 95% confidence ...

Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial. JAMA. 2022;328(8):719-727. Chan NC, Bhandari M.

Oral edoxaban showed superior results to subcutaneous enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty, according to findings published in Thrombosis Journal.

News tagged with enoxaparin. Date. 6 hours 12 hours 1 day 3 days all. Rank. Last day 1 week 1 month all. LiveRank. Last day 1 week 1 month all. Popular. Last day 1 week 1 month all. Medications.

A total of 3604 patients underwent randomization; 1809 patients were assigned to receive rivaroxaban, and 1795 to receive enoxaparin. Major venous thromboembolism occurred in 4 of 1661 patients (0 ...

The secondary outcome of major venous thromboembolism (the composite of adjudicated proximal deep-vein thrombosis, nonfatal pulmonary embolism, and VTE-related death) and death from any cause ...

Implementation of a risk-based chemoprophylaxis protocol using either aspirin or low-molecular weight heparin decreased the incidence of venous thromboembolism among patients who underwent knee ...

Apixaban 2.5 mg twice daily significantly decreased the incidence of venous thromboembolism compared with enoxaparin 40 mg once daily, but not enoxaparin 30 mg twice daily.